相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
Zinal S. Chheda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Subcutaneous Nanodisc Vaccination with Neoantigens for Combination Cancer Immunotherapy
Rui Kuai et al.
BIOCONJUGATE CHEMISTRY (2018)
Macromolecule nanotherapeutics: approaches and challenges
Puneet Tyagi et al.
DRUG DISCOVERY TODAY (2018)
Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy
Rui Kuai et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation
Alyssa K. Kosmides et al.
NANO LETTERS (2018)
Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells
Alexander S. Cheung et al.
NATURE BIOTECHNOLOGY (2018)
Material aid for vaccines
Darrell Irvine
NATURE MATERIALS (2018)
A facile approach to enhance antigen response for personalized cancer vaccination
Aileen Weiwei Li et al.
NATURE MATERIALS (2018)
EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens
Mario Leonardo Squadrito et al.
NATURE METHODS (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
Janos L. Tanyi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Structural absorption by barbule microstructures of super black bird of paradise feathers
Dakota E. McCoy et al.
NATURE COMMUNICATIONS (2018)
An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells
Peng Wang et al.
THERANOSTICS (2018)
Injectable, Tough Alginate Cryogels as Cancer Vaccines
Ting-Yu Shih et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Rui Kuai et al.
SCIENCE ADVANCES (2018)
Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy
Kuangda Lu et al.
NATURE BIOMEDICAL ENGINEERING (2018)
The dawn of vaccines for cancer prevention
Olivera J. Finn
NATURE REVIEWS IMMUNOLOGY (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Comprehensive analysis of the clinical immuno-oncology landscape
J. Tang et al.
ANNALS OF ONCOLOGY (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles
Elias J. Sayour et al.
ONCOIMMUNOLOGY (2017)
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Tyrel T. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound
Kelsie F. Timbie et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
Tyrel T. Smith et al.
NATURE NANOTECHNOLOGY (2017)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Yuanzeng Min et al.
NATURE NANOTECHNOLOGY (2017)
18F-FDG PET/CT-based early treatment response evaluation of nanoparticle-assisted photothermal cancer therapy
Kamilla Norregaard et al.
PLOS ONE (2017)
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Viktor A. Adalsteinsson et al.
NATURE COMMUNICATIONS (2017)
In situ click chemistry generation of cyclooxygenase-2 inhibitors
Atul Bhardwaj et al.
NATURE COMMUNICATIONS (2017)
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Martin Lauss et al.
NATURE COMMUNICATIONS (2017)
Personalized T cell-mediated cancer immunotherapy: progress and challenges
Michael T. Bethune et al.
CURRENT OPINION IN BIOTECHNOLOGY (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Adjuvant-Loaded Spiky Gold Nanoparticles for Activation of Innate Immune Cells
Jutaek Nam et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2017)
Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors
Yiran Zheng et al.
ACS NANO (2017)
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Benjamin Besse et al.
ONCOIMMUNOLOGY (2016)
Spatial Control of Gene Expression by Nanocarriers Using Heparin Masking and Ultrasound-Targeted Microbubble Destruction
Beata Chertok et al.
ACS NANO (2016)
High-Density Lipoproteins: Nature's Multifunctional Nanoparticles
Rui Kuai et al.
ACS NANO (2016)
Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy
Yuan Qian et al.
BIOMATERIALS (2016)
Folate-conjugated gene-carrying microbubbles with focused ultrasound for concurrent blood-brain barrier, opening and local gene delivery
Ching-Hsiang Fan et al.
BIOMATERIALS (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Dendritic cell-derived exosomes for cancer therapy
Jonathan M. Pitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound
Brian P. Mead et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
Designing hydrogels for controlled drug delivery
Jianyu Li et al.
NATURE REVIEWS MATERIALS (2016)
Radiotherapy: Changing the Game in Immunotherapy
Sandra Demaria et al.
TRENDS IN CANCER (2016)
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant
Kobe Reynders et al.
CANCER TREATMENT REVIEWS (2015)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
Immunogenic peptide discovery in cancer genomes
Alexandra Snyder et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2015)
Gene delivery to the spinal cord using MRI-guided focused ultrasound
D. Weber-Adrian et al.
GENE THERAPY (2015)
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Matthew M. Gubin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma
Maxim A. Shevtsov et al.
JOURNAL OF CONTROLLED RELEASE (2015)
18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry
Bruce E. Hillner et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study
Julia Aliz Baan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Injectable cryogel-based whole-cell cancer vaccines
Sidi A. Bencherif et al.
NATURE COMMUNICATIONS (2015)
Injectable, Pore-Forming Hydrogels for In Vivo Enrichment of Immature Dendritic Cells
Catia S. Verbeke et al.
ADVANCED HEALTHCARE MATERIALS (2015)
Review of the results of WT1 peptide vaccination strategies for myelodysplastic syndromes and acute myeloid leukemia from nine different studies
Antonio Di Stasi et al.
FRONTIERS IN IMMUNOLOGY (2015)
Role of Local Radiation Therapy in Cancer Immunotherapy
Sandra Demaria et al.
JAMA ONCOLOGY (2015)
TBCRC 008: Early Change in 18F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2-Negative Primary Operable Breast Cancer
Roisin M. Connolly et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Biopolymer implants enhance the efficacy of adoptive T-cell therapy
Sirkka B. Stephan et al.
NATURE BIOTECHNOLOGY (2015)
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Yuchen Fan et al.
VACCINES (2015)
Ultrasound induced cancer immunotherapy
Johan Unga et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
Raquel P. Deering et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Combinations of Radiation Therapy and Immunotherapy for Melanoma: A Review of Clinical Outcomes
Christopher A. Barker et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
Charlene M. Dawidczyk et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Textural Parameters of Tumor Heterogeneity in 18F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer
Ralph A. Bundschuh et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Multifunctional Tumor pH-Sensitive Self-Assembled Nanoparticles for Bimodal Imaging and Treatment of Resistant Heterogeneous Tumors
Daishun Ling et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Ultrasound-activated Agents Comprised of 5FU-bearing Nanoparticles Bonded to Microbubbles Inhibit Solid Tumor Growth and Improve Survival
Caitlin W. Burke et al.
MOLECULAR THERAPY (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
Microfluidic organs-on-chips
Sangeeta N. Bhatia et al.
NATURE BIOTECHNOLOGY (2014)
A carbon nanotube-polymer composite for T-cell therapy
Tarek R. Fadel et al.
NATURE NANOTECHNOLOGY (2014)
Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
Zineb Belcaid et al.
PLOS ONE (2014)
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses
Hyun-Il Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
Towards a vaccine to prevent cancer in Lynch syndrome patients
Magnus von Knebel Doeberitz et al.
FAMILIAL CANCER (2013)
Improving ultrasound gene transfection efficiency by controlling ultrasound excitation of microbubbles
Z. Fan et al.
JOURNAL OF CONTROLLED RELEASE (2013)
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
Yiran Zheng et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Subnanometer Local Temperature Probing and Remotely Controlled Drug Release Based on Azo-Functionalized Iron Oxide Nanoparticles
Andreas Riedinger et al.
NANO LETTERS (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
RNA: The new revolution in nucleic acid vaccines
Andrew J. Geall et al.
SEMINARS IN IMMUNOLOGY (2013)
Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
Koichiro Hayashi et al.
THERANOSTICS (2013)
Scavenger Receptor B1 is a Potential Biomarker of Human Nasopharyngeal Carcinoma and Its Growth is Inhibited by HDL-mimetic Nanoparticles
Ying Zheng et al.
THERANOSTICS (2013)
The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics
Pedro M. R. Cruz et al.
FRONTIERS IN PHARMACOLOGY (2013)
Multimodal Imaging Guided Photothermal Therapy using Functionalized Graphene Nanosheets Anchored with Magnetic Nanoparticles
Kai Yang et al.
ADVANCED MATERIALS (2012)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery
Susan M. van Dommelen et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens
Frank Wegmann et al.
NATURE BIOTECHNOLOGY (2012)
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Pedro M. Valencia et al.
NATURE NANOTECHNOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Developing mRNA-vaccine technologies
Thomas Schlake et al.
RNA BIOLOGY (2012)
Combining immunotherapy and targeted therapies in cancer treatment
Matthew Vanneman et al.
NATURE REVIEWS CANCER (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
Kazuhiro Kakimi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Valerie Bonadona et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Camilo E. Fadul et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Exchange-coupled magnetic nanoparticles for efficient heat induction
Jae-Hyun Lee et al.
NATURE NANOTECHNOLOGY (2011)
Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles
Mian M. K. Shahzad et al.
NEOPLASIA (2011)
Imaging of cellular therapies
M. Srinivas et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
Sebastian Kreiter et al.
CANCER RESEARCH (2010)
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine
H. S. Gill et al.
GENE THERAPY (2010)
Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice
ZhenZhen Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Matthias T. Stephan et al.
NATURE MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Regulation of Adaptive Immunity by the Innate Immune System
Akiko Iwasaki et al.
SCIENCE (2010)
MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression
Chen Guihua et al.
BIOMATERIALS (2009)
Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients
Thomas Schwaab et al.
CLINICAL CANCER RESEARCH (2009)
Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection
Jing-Yan Cheng et al.
JOURNAL OF CONTROLLED RELEASE (2009)
A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy
Ryo Suzuki et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells
Ekaterina I. Galanzha et al.
NATURE NANOTECHNOLOGY (2009)
Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer
Shengming Dai et al.
MOLECULAR THERAPY (2008)
DNA vaccines: ready for prime time?
Michele A. Kutzler et al.
NATURE REVIEWS GENETICS (2008)
DNA vaccines: precision tools for activating effective immunity against cancer
Jason Rice et al.
NATURE REVIEWS CANCER (2008)
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity
Martijn S. Bijker et al.
JOURNAL OF IMMUNOLOGY (2007)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound
Lisa H. Treat et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response
Alex Jv Thompson et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Targeted delivery of magnetic aerosol droplets to the lung
Petra Dames et al.
NATURE NANOTECHNOLOGY (2007)
Microfluidic directed formation of liposomes of controlled size
Andreas Jahn et al.
LANGMUIR (2007)
Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin
Sven Wittrock et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12
Chang-Hyun Kim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
H Kato et al.
NATURE (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers
S Varghese et al.
CANCER GENE THERAPY (2006)
Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma
HL Kaufman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial
B Escudier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
MA Morse et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Multi-step synthesis of nanoparticles performed on millisecond time scale in a microfluidic droplet-based system
I Shestopalov et al.
LAB ON A CHIP (2004)
Progress and prospects: naked DNA gene transfer and therapy
H Herweijer et al.
GENE THERAPY (2003)
Exosomes:: Composition, biogenesis and function
C Théry et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen
WF Cheng et al.
JOURNAL OF VIROLOGY (2001)
Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100
MC Panelli et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
JN Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
被撤回的出版物: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids (Retracted article. See vol. 9, p. 1221, 2003)
A Kugler et al.
NATURE MEDICINE (2000)
分享论文
